DANIELLE PARRISH: Open Payments
NPI 1720043789 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 109 payments from 22 companies in 2025. Trend: 2023 $918 · 2024 $1,208 · 2025 $2,075
Food & beverage: $1,949Education: $126
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 22 | $279 |
| AstraZeneca Pharmaceuticals LP | 12 | $263 |
| Regeneron Healthcare Solutions, Inc. | 10 | $252 |
| GENZYME CORPORATION | 8 | $213 |
| Insmed, Inc. | 10 | $180 |
| Merck Sharp & Dohme LLC | 8 | $145 |
| ANI Pharmaceuticals, Inc. | 5 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $91 |
| Actelion Pharmaceuticals US, Inc. | 4 | $75 |
| Viatris Specialty LLC | 4 | $67 |
Products named: DUPIXENT, NUCALA, Brinsupri, FASENRA, PURIFIED CORTROPHIN GEL, TRELEGY ELLIPTA, ZERBAXA, YUPELRI.
Industry payments across NC — which companies pay providers there.
